Skip to Main Content

Author Details

Aidong Zhou
Southern Medical University
2002
34
17
PMIDPaper TitleJournal TitlePublished Year
37523556SEC61G assists <i>EGFR</i>-amplified glioblastoma to evade immune elimination.Proc Natl Acad Sci U S A2023
36197973Critical role of lncEPAT in coupling dysregulated EGFR pathway and histone H2A deubiquitination during glioblastoma tumorigenesis.Sci Adv2022
36333288Derepression of the USP22-FASN axis by p53 loss under oxidative stress drives lipogenesis and tumorigenesis.Cell Death Discov2022
35990696Optimization of cancer immunotherapy through pyroptosis: A pyroptosis-related signature predicts survival benefit and potential synergy for immunotherapy in glioma.Front Immunol2022
33597240Relaxed initiation pausing of ribosomes drives oncogenic translation.Sci Adv2021
31888886Wnt-Induced Stabilization of KDM4C Is Required for Wnt/β-Catenin Target Gene Expression and Glioblastoma Tumorigenesis.Cancer Res2020
30425057Aberrant Activation of β-Catenin Signaling Drives Glioma Tumorigenesis via USP1-Mediated Stabilization of EZH2.Cancer Res2019
28699529Targeting Protein Kinases for the Treatment of Glioblastoma Multiforme: Linking Basic Studies to Clinical Applications.Curr Pharm Des2017
28344040m<sup>6</sup>A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program.Cancer Cell2017
28623188Gli1-induced deubiquitinase USP48 aids glioblastoma tumorigenesis by stabilizing Gli1.EMBO Rep2017
26912724Wnt-induced deubiquitination FoxM1 ensures nucleus β-catenin transactivation.EMBO J2016
27501329Nuclear GSK3β promotes tumorigenesis by phosphorylating KDM1A and inducing its deubiquitylation by USP22.Nat Cell Biol2016
27285761Wnt/β-catenin pathway transactivates microRNA-150 that promotes EMT of colorectal cancer cells by suppressing CREB signaling.Oncotarget2016
27246830miR-182-5p Induced by STAT3 Activation Promotes Glioma Tumorigenesis.Cancer Res2016
25639486Tumour suppressor TRIM33 targets nuclear β-catenin degradation.Nat Commun2015
26372013Bacterial Diversity and Community Structure in the Pine Wood Nematode Bursaphelenchus xylophilus and B. mucronatus with Different Virulence by High-Throughput Sequencing of the 16S rDNA.PLoS One2015
26085085Forkhead Box M1 Is Essential for Nuclear Localization of Glioma-associated Oncogene Homolog 1 in Glioblastoma Multiforme Cells by Promoting Importin-7 Expression.J Biol Chem2015
25869208FoxM1 promotes breast tumorigenesis by activating PDGF-A and forming a positive feedback loop with the PDGF/AKT signaling pathway.Oncotarget2015
25832656FoxM1 Drives a Feed-Forward STAT3-Activation Signaling Loop That Promotes the Self-Renewal and Tumorigenicity of Glioblastoma Stem-like Cells.Cancer Res2015
25881542Stat3 orchestrates interaction between endothelial and tumor cells and inhibition of Stat3 suppresses brain metastasis of breast cancer cells.Oncotarget2015
23709169Isolation and identification of phytate-degrading rhizobacteria with activity of improving growth of poplar and Masson pine.World J Microbiol Biotechnol2013
23886084[A clinical analysis for sudden sensorineural hearing loss with acoustic neurinoma].Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi2013
22020335β-Catenin/LEF1 transactivates the microRNA-371-373 cluster that modulates the Wnt/β-catenin-signaling pathway.Oncogene2012
22977194FoxM1 inhibition sensitizes resistant glioblastoma cells to temozolomide by downregulating the expression of DNA-repair gene Rad51.Clin Cancer Res2012
21903586miR-125b, a target of CDX2, regulates cell differentiation through repression of the core binding factor in hematopoietic malignancies.J Biol Chem2011
19593659Functional characterization of the promoter region of human TNFAIP1 gene.Mol Biol Rep2010
19154347Transcription factor specificity protein 1 (SP1) and activating protein 2alpha (AP-2alpha) regulate expression of human KCTD10 gene by binding to proximal region of promoter.FEBS J2009
18721783A nuclear localized protein ZCCHC9 is expressed in cerebral cortex and suppresses the MAPK signal pathway.J Genet Genomics2008
19119673[Pathological features and clinical managements of nasopharyngeal angiofibroma].Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi2008
17295934Huge nasopharyngeal angiofibroma with intracranial extension: change in the dura mater and choice of surgical management.J Laryngol Otol2007
16883529[Mitochondrial 12S rRNA gene A827G in two pedigrees with nonsyndromic deafness].Zhonghua Yi Xue Yi Chuan Xue Za Zhi2006
16870576[Expression profile in the cell lines of human TNFAIP1 gene].Yi Chuan2006
15757666Genomic organization, promoter characterization and roles of Sp1 and AP-2 in the basal transcription of mouse PDIP1 gene.FEBS Lett2005
12575254[Researching some sensitivity factor of bioassay method on the antibiotics pharmacokinetics].Hunan Yi Ke Da Xue Xue Bao2002
  • 1 - 34 of 34

Recommended Authors

Princess Margaret Hospital
Career Start Year 2013
Number of shared co-authors 2
Research Center for Nano-Biomaterials, Sichuan University
Career Start Year 2013
Number of shared co-authors 0
School of Pharmacy, Wannan Medical College
Career Start Year 2012
Number of shared co-authors 0
Seoul National University, College of Medicine
Career Start Year 2010
Number of shared co-authors 1
Center for Global Health, School of Public Health, Nanjing Medical University
Career Start Year 2009
Number of shared co-authors 13
National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 1
Beijing University of Chinese Medicine
Career Start Year 2007
Number of shared co-authors 0
Tangdu Hospital, Fourth Military Medical University
Career Start Year 2006
Number of shared co-authors 0
West China Hospital, Sichuan University
Career Start Year 2005
Number of shared co-authors 0
University of Tennessee Health Science Center
Career Start Year 2004
Number of shared co-authors 2
Huaihe Hospital of Henan University
Career Start Year 2004
Number of shared co-authors 0
International Centre for Genetic Engineering and Biotechnology
Career Start Year 2004
Number of shared co-authors 0
Shandong University of Traditional Chinese Medicine
Career Start Year 2003
Number of shared co-authors 0
The University of Hong Kong
Career Start Year 2003
Number of shared co-authors 0
Aier Eye Hospital of Wuhan University
Career Start Year 2001
Number of shared co-authors 3
Cancer Stem Cell Research Center, Samsung Biomedical Research Institute
Career Start Year 2001
Number of shared co-authors 2
Research Institute, National Cancer Center
Career Start Year 2000
Number of shared co-authors 1
West China Second Hospital, Sichuan University
Career Start Year 2000
Number of shared co-authors 0
Mossakowski Medical Research Institute, Polish Academy of Sciences
Career Start Year 1999
Number of shared co-authors 1
Chengdu Medical College
Career Start Year 1999
Number of shared co-authors 0
Basic Medical College, Qingdao University
Career Start Year 1998
Number of shared co-authors 1
Research Institute, National Cancer Center
Career Start Year 1998
Number of shared co-authors 1
University of Alabama at Birmingham
Career Start Year 1997
Number of shared co-authors 1
Henan-Macquarie University Joint Centre for Biomedical Innovation, Henan University
Career Start Year 1997
Number of shared co-authors 4
Fujian Medical University Cancer Hospital and Fujian Cancer Hospital
Career Start Year 1996
Number of shared co-authors 0
Northwestern University Feinberg School of Medicine
Career Start Year 1996
Number of shared co-authors 4
Samsung Genome Institute, Samsung Medical Center
Career Start Year 1995
Number of shared co-authors 4
Northwestern University
Career Start Year 1992
Number of shared co-authors 2
Peking University Cancer Hospital
Career Start Year 1989
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 11

Collaborators

Virginia Commonwealth University
Co-authored papers 14
The University of Texas MD Anderson Cancer Center
Co-authored papers 8
The University of Texas MD Anderson Cancer Center
Co-authored papers 7
The South China University of Technology Comprehensive Cancer Center
Co-authored papers 6
The University of Texas MD Anderson Cancer Center
Co-authored papers 5
National Cancer Institute
Co-authored papers 4
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Northwestern University Feinberg School of Medicine
Co-authored papers 2
Co-authored papers 2
MD Anderson Cancer Center
Co-authored papers 2
Greehey Children's Cancer Research Institute
Co-authored papers 1
Institute of Hematology, West China Hospital of Sichuan University
Co-authored papers 1
Yale School of Medicine
Co-authored papers 1
The University of Chicago
Co-authored papers 1
The University of Texas M.D. Anderson Cancer Center
Co-authored papers 1
American Association for Cancer Research, Henry Ford Hospital, Ludwig Institute for Cancer Research, National Cancer Institute, Salk Institute for Biological Studies, University of Cambridge, University of Texas MD Anderson Cancer Center, Virginia Commonwealth University
Co-authored papers 1
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
The University of Texas M.D. Anderson Cancer Center
Co-authored papers 1
NYU Grossman School of Medicine
Co-authored papers 1
The University of Texas M.D. Anderson Cancer Center, American University of Beirut
Co-authored papers 1
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital
Co-authored papers 1
Center for Genome Editing
Co-authored papers 1
The University of Texas MD Anderson Cancer Center
Co-authored papers 1